spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

Right arrow Help viewing high resolution images
Right arrow Return to article
(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.


Figure 5


Fig. 5. In the absence of L chains, µ{Delta}CH1 condense primarily in tubular vesicles and saccules enriched in ERGIC-53. (a-f) H[µ{Delta}CH1] cells were cultured with (a,b) or without tetracycline for 3 (c,d) or 7 days (e,f) and stained with antibodies against ERGIC-53 (a,c,e in green), GM130 (b,d,f; green) or µ (c-f; red). Note that ERGIC-53 abandons its canonical distribution (a) to co-localize with µ{Delta}CH1-containing sRB upon tetracycline removal (panels c,e yellow staining). µ{Delta}CH1 accumulates close to GM130, but does not overlap with it (d,f); bar, 5 µm. (g,h) After 7 days of culture without tetracycline, cells were processed for cryo-EM with anti-µ (g) or anti-ERGIC-53 (h, G1/93) antibodies and revealed with protein-A coupled to 15 nm gold particles. µ{Delta}CH1 chains accumulate in saccules enriched in ERGIC-53. Bars, 100 nm. (i,j) H[µ{Delta}CH1] cells were kept for 7 days without tetracycline and processed for resin embedding and EM. Continuity between rough ER and µ{Delta}CH1-containing sRB are evident in j (see arrow; the arrowheads point to regions rich in ribosomes). Bars, 100 nm.





Right arrow Return to article